SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-16-012041
Filing Date
2016-04-08
Accepted
2016-04-08 16:06:37
Documents
12
Period of Report
2016-05-25
Effectiveness Date
2016-04-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2228124zdef14a.htm DEF 14A 668663
2 G651724.JPG g651724.jpg GRAPHIC 10236
3 G28654.JPG g28654.jpg GRAPHIC 6567
4 G407006.JPG g407006.jpg GRAPHIC 5158
5 G24402BGI001.GIF g24402bgi001.gif GRAPHIC 105667
6 G24402BGI002.GIF g24402bgi002.gif GRAPHIC 46992
7 G24402BII001.GIF g24402bii001.gif GRAPHIC 56561
8 G24402BII002.GIF g24402bii002.gif GRAPHIC 45431
9 G24402BKI001.GIF g24402bki001.gif GRAPHIC 41326
10 G24402BKI002.GIF g24402bki002.gif GRAPHIC 63881
11 G24402BKI003.GIF g24402bki003.gif GRAPHIC 26514
12 G24402BKI004.GIF g24402bki004.gif GRAPHIC 20966
  Complete submission text file 0001047469-16-012041.txt   1261796
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35619 | Film No.: 161562761
SIC: 2834 Pharmaceutical Preparations